1. Home
  2. EFR vs ALT Comparison

EFR vs ALT Comparison

Compare EFR & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EFR
  • ALT
  • Stock Information
  • Founded
  • EFR 2003
  • ALT 1997
  • Country
  • EFR United States
  • ALT United States
  • Employees
  • EFR N/A
  • ALT N/A
  • Industry
  • EFR Trusts Except Educational Religious and Charitable
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • EFR Finance
  • ALT Health Care
  • Exchange
  • EFR Nasdaq
  • ALT Nasdaq
  • Market Cap
  • EFR 344.0M
  • ALT 292.0M
  • IPO Year
  • EFR N/A
  • ALT N/A
  • Fundamental
  • Price
  • EFR $11.71
  • ALT $3.83
  • Analyst Decision
  • EFR
  • ALT Strong Buy
  • Analyst Count
  • EFR 0
  • ALT 6
  • Target Price
  • EFR N/A
  • ALT $17.40
  • AVG Volume (30 Days)
  • EFR 88.6K
  • ALT 3.0M
  • Earning Date
  • EFR 01-01-0001
  • ALT 08-12-2025
  • Dividend Yield
  • EFR 9.43%
  • ALT N/A
  • EPS Growth
  • EFR N/A
  • ALT N/A
  • EPS
  • EFR 1.69
  • ALT N/A
  • Revenue
  • EFR N/A
  • ALT $20,000.00
  • Revenue This Year
  • EFR N/A
  • ALT N/A
  • Revenue Next Year
  • EFR N/A
  • ALT $761,880.20
  • P/E Ratio
  • EFR $7.74
  • ALT N/A
  • Revenue Growth
  • EFR N/A
  • ALT N/A
  • 52 Week Low
  • EFR $10.95
  • ALT $2.90
  • 52 Week High
  • EFR $13.29
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • EFR 43.60
  • ALT 51.79
  • Support Level
  • EFR $11.64
  • ALT $3.35
  • Resistance Level
  • EFR $11.79
  • ALT $3.66
  • Average True Range (ATR)
  • EFR 0.09
  • ALT 0.19
  • MACD
  • EFR 0.01
  • ALT 0.07
  • Stochastic Oscillator
  • EFR 60.00
  • ALT 86.18

About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest

Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: